Home / Sweden / Hansa Biopharma AB
Hansa Biopharma AB
Short position disclosed on August 11, 2026.
2.08% of the capital sold short
3 disclosing funds
428 disclosures on record
SE0002148817 ISIN code
Funds holding Hansa Biopharma AB Titelia
Evolution of the disclosed total
0%2%4%6%
Oct 2025Jan 2026Apr 2026Jul 2026
January 15, 2019 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| ActusRayPartners Limited | 0.89% | +0.29 pt | August 7, 2026 | |
| GSA Capital Partners LLP | 0.60% | +0.06 pt | August 6, 2026 | |
| Connor Clark & Lunn Investment Management Ltd. | 0.59% | -0.02 pt | August 11, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 15, 2019 | Worldquant, LLC | 0.60% | still open |
| August 13, 2019 | Voleon Capital Management LP | 0.59% | still open |
| August 13, 2019 | Worldquant, LLC | 0.59% | still open |
| August 12, 2019 | Voleon Capital Management LP | 0.59% | still open |
| August 12, 2019 | Worldquant, LLC | 0.59% | still open |
| August 1, 2019 | Voleon Capital Management LP | 0.68% | still open |
| July 31, 2019 | Voleon Capital Management LP | 0.68% | still open |
| July 18, 2019 | Voleon Capital Management LP | 0.72% | still open |
| July 17, 2019 | Voleon Capital Management LP | 0.72% | still open |
| July 11, 2019 | Voleon Capital Management LP | 0.60% | still open |
| July 10, 2019 | Voleon Capital Management LP | 0.60% | still open |
| July 2, 2019 | Worldquant, LLC | 0.60% | still open |
| July 1, 2019 | Worldquant, LLC | 0.60% | still open |
| July 1, 2019 | Voleon Capital Management LP | 0.50% | still open |
| June 30, 2019 | Voleon Capital Management LP | 0.50% | still open |
| June 26, 2019 | Worldquant, LLC | 0.50% | still open |
| June 25, 2019 | Worldquant, LLC | 0.50% | still open |
| May 23, 2019 | Worldquant, LLC | 0.00% | still open |
| May 13, 2019 | Worldquant, LLC | 0.50% | still open |
| May 12, 2019 | Worldquant, LLC | 0.50% | still open |
| February 11, 2019 | Marshall Wace LLP | 0.00% | still open |
| February 8, 2019 | Worldquant, LLC | 0.00% | still open |
| February 1, 2019 | Marshall Wace LLP | 0.58% | still open |
| January 31, 2019 | Marshall Wace LLP | 0.58% | still open |
| January 31, 2019 | Worldquant, LLC | 0.50% | still open |
| January 30, 2019 | Worldquant, LLC | 0.50% | still open |
| January 16, 2019 | Marshall Wace LLP | 0.69% | still open |
| January 15, 2019 | Marshall Wace LLP | 0.69% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
- Elekta AB (publ) 10.19% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Embracer Group AB 5.25% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Dynavox Group AB 4.30% of the capital sold short
- RaySearch Laboratories AB (publ) 4.15% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Hansa Biopharma AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/hansa-biopharma-ab?page=9